Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of $0.22, $0.01 better than the analyst estimate of $0.21. Revenue for the quarter came in at $996 million versus the consensus estimate of $961.31 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.